ERAS-601

Other Medications

EU Not submitted to EMA ES Not available 1 Clinical Trials

Description

ERAS-601 is an experimental medication currently being studied in clinical trials for various advanced solid tumors, including colorectal cancer. It is being investigated as a potential treatment option, either alone or in combination with other cancer therapies like cetuximab or pembrolizumab. This is a Phase 1 trial, meaning it is primarily designed to determine the safest dose of ERAS-601 and to see how patients respond to it. The trial is open-label, meaning both the researchers and the patients know which treatment is being given. ERAS-601 is being studied in patients whose tumors have specific molecular changes that might make them sensitive to this drug. It is not yet approved for use in colorectal cancer or any other cancer.

Mechanism of Action

ERAS-601 is being studied as a first-in-human therapy. The specific way it works (its mechanism of action) is still being investigated in clinical trials. Researchers are exploring its potential effects on cancer cells and the tumor environment. The trials aim to understand how ERAS-601 interacts with the body and its potential impact on tumor growth and spread.

Side Effects

As ERAS-601 is an experimental drug in Phase 1 trials The full range of potential side effects is still being evaluated. The primary goal of Phase 1 trials is to assess safety So researchers are closely monitoring patients for any adverse events. Specific side effects observed in the trials are not detailed in the provided information But common side effects in early-phase cancer trials can vary widely depending on the drug and the dose. Patients participating in the trial will have their health closely monitored.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04670679 Phase 1
Active, not recruiting
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
United States, Australia

Quick Info

CategoryOther Medications
EU EMA StatusNot submitted to EMA
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
786 trials
Leucovorin
Other Medications
647 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.